Brenus Pharma

Issoire, France · Founded 2014 · Privately Held (backing)

Developer of anti-cancer cell-based immunotherapy designed to generate allogeneic cell vaccines for solid tumors. Brenus Pharma is based in Issoire, France and was founded in 2014. Its last known valuation is $45.4 million. It has raised $30 million.

Last price · $/share
—
Implied valuation
$45.4M
Total raised
$30.0M
Last round
—
What is Brenus Pharma worth?
$45.4Mlast known valuation
Free account
More of Brenus Pharma with a free account
  • ·The complete investor list: 11 names
  • ·Watch Brenus Pharma: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Brenus Pharma funding history

No rounds on record

No funding rounds for Brenus Pharma are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

Brenus Pharma valuation

Brenus Pharma's last known valuation is $45.4 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.

How Brenus Pharma's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Brenus Pharma, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked about Brenus Pharma

What is Brenus Pharma worth?
Brenus Pharma's last known valuation is $45.4M.
How much has Brenus Pharma raised?
Brenus Pharma has raised $30.0M in total funding across its recorded rounds.